Zydus Cadila begins enrolment for Phase 3 vaccine trial: Reports
India Published: Friday, January 22, 2021, 11:37 [IST]
New Delhi, Jan 22: Zydus Cadila has started enrolling and dosing participants in India for the Phase 3 clinical trial of its three-dose COVID-19 vaccine ZyCoV-D, according to reports.
The trials are expected to take place across four cities - Surat, Nashik, Jaipur and Ahmedabad.
Representational Image
Zydus Cadila received DCGI s approval earlier this month to initiate Phase 3 trials in 26,000 Indian participants. We started enrolment and dosing of participants from Saturday. The enrolment and dosing happens between 9am and 5pm, the principal investigator at a trial site, one of the two people mentioned above, said on condition of anonymity.
Vaccination drive is being done on three days in a week in the city.
SURAT: Surat Municipal Corporation (SMC) has rolled out a vaccination programme against the Covid-19 in the city and till now, total 2,544 frontline health workers in government as well as private hospitals in the city.
Vaccination drive is being done on three days in a week Tuesday, Thursday and Saturday in the city.
SMC is expecting that the first phase of the vaccination of healthcare workers will be completed by the first week of February and then the second dose of vaccination will begin alongside the first round of vaccination to workers.